CRISPR and CAS Gene Technology Market - Top Companies and Manufacturers

Companies Dominating the CRISPR and CAS Gene Technology Landscape

Thermo Fisher Scientific Holdings, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Origene Technologies
Addgene, Inc.
Merck KGaA
GenScript Biotech
Cellecta, Inc.
Caribou Bioscience, Inc.
Horizon Discovery Group
Mammoth Biosciences, Inc.
Inscripta, Inc.

Browse Key Market Insights with Data Illustration:

CRISPR and CAS Gene Technology Market Size, Growth Forecasts 2037

In the News

GenScript Biotech entered into an agreement with InnoBation Co. Ltd. for the cell line development and engineering of GMP plasmids and lentivirus. Through this agreement, GenScript is aiming to provide CRO services to InnoBation by using CRISPR and CAS gene technology.
University of Connecticut Health Center developed “All-In-One Dual CRISPR-Cas 12a (AIOD-CRISPR)” assay method, which performs ultrasensitive, specific, and visual detection of nucleic acid in the SARS-COV-2 virus and can test for COVID-19 infection at a quicker pace.
Mammoth Biosciences, Inc. developed a new CRISPR technology-based test for COVID- 19 detections called “SARS-COV-2 DETECTR”, which can take out results within an hour of the test using loop-mediated amplification and CAS12 enzyme.

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of CRISPR and CAS gene technology is estimated at USD 5.65 billion.

The CRISPR and CAS gene technology market size was over USD 4.85 billion in 2024 and is likely to cross USD 33.05 billion by the end of 2037, witnessing more than 20.4% CAGR during the forecast period i.e., between 2025-2037. The rising applications of CRISPR and CAS gene technology and the increasing government and private funding for medical research will impel the market growth.

North American industry is projected to have the highest growth through 2037, led by increasing investment of governmental and non-governmental agencies in R&D activities.

The major players in the market include Thermo Fisher Scientific Holdings, Inc., Origene Technologies, Addgene, Inc., Merck KGaA, GenScript Biotech, Cellecta, Inc., Caribou Bioscience, Inc., Horizon Discovery Group, Mammoth Biosciences, Inc., Inscripta, Inc.

CRISPR and CAS Gene Technology Market - Top Companies and Manufacturers

Companies Dominating the CRISPR and CAS Gene Technology Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What is the size of the CRISPR and CAS gene technology market?

Why is the CRISPR and CAS gene technology sector gaining traction in near future?

Which region accounted for the largest CRISPR and CAS gene technology industry share?

Who are the major CRISPR and CAS gene technology players?